-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Reviewing Escalon Medical (OTCMKTS:ESMC) and Vivani Medical (NASDAQ:VANI)
Reviewing Escalon Medical (OTCMKTS:ESMC) and Vivani Medical (NASDAQ:VANI)
Escalon Medical (OTCMKTS:ESMC – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability.
Valuation & Earnings
This table compares Escalon Medical and Vivani Medical's gross revenue, earnings per share (EPS) and valuation.
Get Escalon Medical alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Escalon Medical | $10.70 million | 0.05 | $20,000.00 | N/A | N/A |
Vivani Medical | $3.38 million | 4.00 | -$8.92 million | N/A | N/A |
Escalon Medical has higher revenue and earnings than Vivani Medical.
Risk & Volatility
Escalon Medical has a beta of -0.52, meaning that its share price is 152% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.45, meaning that its share price is 145% more volatile than the S&P 500.Profitability
This table compares Escalon Medical and Vivani Medical's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Escalon Medical | -5.83% | -77.30% | -12.18% |
Vivani Medical | N/A | -8.27% | -7.86% |
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Escalon Medical and Vivani Medical, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Escalon Medical | 0 | 0 | 0 | 0 | N/A |
Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
Vivani Medical has a consensus price target of $7.00, suggesting a potential upside of 579.61%. Given Vivani Medical's higher probable upside, analysts clearly believe Vivani Medical is more favorable than Escalon Medical.
Summary
Vivani Medical beats Escalon Medical on 7 of the 9 factors compared between the two stocks.
About Escalon Medical
(Get Rating)
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices regardless of modality, manufacturer or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is based in Wayne, Pennsylvania.
About Vivani Medical
(Get Rating)
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Escalon Medical (OTCMKTS:ESMC – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability.
埃斯卡隆医疗(场外交易代码:ESMC-GET评级)和维瓦尼医疗(纳斯达克:VANI-GET评级)都是小盘医疗公司,但哪只股票更好?我们将根据两家公司的风险、机构持股、分析师建议、收益、股息、估值和盈利能力的强弱对它们进行比较。
Valuation & Earnings
估值与收益
This table compares Escalon Medical and Vivani Medical's gross revenue, earnings per share (EPS) and valuation.
该表比较了Escalon Medical和Vivani Medical的毛收入、每股收益(EPS)和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Escalon Medical | $10.70 million | 0.05 | $20,000.00 | N/A | N/A |
Vivani Medical | $3.38 million | 4.00 | -$8.92 million | N/A | N/A |
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
埃斯卡隆医疗公司 | 1070万美元 | 0.05 | $20,000.00 | 不适用 | 不适用 |
维瓦尼医疗 | 338万美元 | 4.00 | -892万元 | 不适用 | 不适用 |
Escalon Medical has higher revenue and earnings than Vivani Medical.
Escalon Medical的收入和收益高于Vivani Medical。
Risk & Volatility
风险与波动性
Profitability
盈利能力
This table compares Escalon Medical and Vivani Medical's net margins, return on equity and return on assets.
此表比较了Escalon Medical和Vivani Medical的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Escalon Medical | -5.83% | -77.30% | -12.18% |
Vivani Medical | N/A | -8.27% | -7.86% |
净利润率 | 股本回报率 | 资产回报率 | |
埃斯卡隆医疗公司 | -5.83% | -77.30% | -12.18% |
维瓦尼医疗 | 不适用 | -8.27% | -7.86% |
Analyst Ratings
分析师评级
This is a breakdown of recent ratings and recommmendations for Escalon Medical and Vivani Medical, as reported by MarketBeat.
这是MarketBeat报道的Escalon Medical和Vivani Medical最近的评级和推荐细目。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Escalon Medical | 0 | 0 | 0 | 0 | N/A |
Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
埃斯卡隆医疗公司 | 0 | 0 | 0 | 0 | 不适用 |
维瓦尼医疗 | 0 | 0 | 1 | 0 | 3.00 |
Vivani Medical has a consensus price target of $7.00, suggesting a potential upside of 579.61%. Given Vivani Medical's higher probable upside, analysts clearly believe Vivani Medical is more favorable than Escalon Medical.
Vivani Medical的一致目标价为7美元,这意味着潜在的上涨幅度为579.61。鉴于Vivani Medical更有可能上行,分析师显然认为Vivani Medical比Escalon Medical更有利。
Summary
摘要
Vivani Medical beats Escalon Medical on 7 of the 9 factors compared between the two stocks.
Vivani Medical在两只股票比较的9个因素中有7个击败了Escalon Medical。
About Escalon Medical
关于埃斯卡隆医疗公司
(Get Rating)
(获取评级)
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices regardless of modality, manufacturer or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is based in Wayne, Pennsylvania.
Escalon医疗公司在美国和国际上开发、制造、营销和分销眼科领域的医疗器械和药品。它提供A-Scan,它提供有关眼睛内部结构的信息;B-Scan,一种诊断工具,向医生提供眼睛内介质混浊或不透明的信息;UBM,一种高频/高分辨率超声设备,提供有关眼睛前段的详细信息;以及Pachyeter,测量角膜厚度。该公司还分销眼内气体产品,如C3F8和SF6,玻璃体-视网膜外科医生在脱离的视网膜手术中将其用作临时填塞;并制造和分销一种获得专利的一次性通用气体套件,将气体从罐中输送到患者手中。此外,它还提供用于玻璃体视网膜手术的一次性手术包;以及AXIS图像管理系统,用于通过网络浏览器管理来自各种设备的眼科诊断图像,而无论设备类型、制造商或位置。该公司通过独立的销售代表、分销商网络和内部销售员工向医疗机构销售其产品。Escalon医疗公司成立于1987年,总部设在宾夕法尼亚州韦恩。
About Vivani Medical
关于维瓦尼医疗公司
(Get Rating)
(获取评级)
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Vivani Medical,Inc.是一家临床阶段公司,开发各种植入物,用于治疗具有高度未满足医疗需求的慢性病。它致力于开发一系列微型药物植入物,以提供波动最小的药物配置文件;以及植入式视觉假体设备,为盲人提供有用的人工视力。该公司总部设在加利福尼亚州埃默里维尔。
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Escalon医学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Escalon Medical和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧